Holen Sie sich die Stockscreener-App
50.60
1.08%
-0.55
Handel nachbörslich:
50.60
Schlusskurs vom Vortag:
$51.15
Offen:
$51.15
24-Stunden-Volumen:
2.86M
Relative Volume:
3.20
Marktkapitalisierung:
$2.44B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$123.81M
KGV:
21.00
EPS:
2.41
Netto-Cashflow:
$20.35M
1W Leistung:
-3.07%
1M Leistung:
-6.81%
6M Leistung:
-22.43%
1J Leistung:
-32.61%
1-Tages-Spanne:
$50.29
$51.50
1-Wochen-Bereich:
$49.43
$52.75
52-Wochen-Spanne:
$49.43
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Branche
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
50.60 | 2.46B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Bestätigt | Barrington Research | Outperform |
| 2025-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-06-26 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-02-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Voya Investment Management LLC Sells 258,200 Shares of Haemonetics Corporation $HAE - Defense World
Haemonetics (NYSE:HAE) Hits New 12-Month LowHere's What Happened - MarketBeat
Custom strategy builders for tracking Haemonetics CorporationTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
Combining machine learning predictions for Haemonetics CorporationEarnings Miss & Low Risk High Reward Ideas - newser.com
Harbor Capital Advisors Inc. Sells 5,899 Shares of Haemonetics Corporation $HAE - MarketBeat
Rate Hike: Is 908 Devices Inc. stock a top performer YTDMarket Risk Summary & Weekly Watchlist for Consistent Profits - khodrobank.com
Using data tools to time your Haemonetics Corporation exitJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Haemonetics Corporation’s volatility index tracking explainedEarnings Beat & Verified High Yield Trade Plans - newser.com
Applying chart zones and confluence areas to Haemonetics CorporationPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Bearish Setup: Can Sigma Lithium Corporation be recession proofJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - khodrobank.com
Long term hold vs stop loss in Haemonetics Corporation2025 Stock Rankings & Smart Money Movement Tracker - newser.com
Is Haemonetics Corporation building a consolidation base2025 Investor Takeaways & Low Volatility Stock Recommendations - newser.com
Chart based analysis of Haemonetics Corporation trendsTrade Entry Summary & Reliable Volume Spike Trade Alerts - newser.com
Haemonetics Corporation (HAE) Launches PerQseal Elite, Advancing Minimally Invasive Vascular Care - Insider Monkey
Real time breakdown of Haemonetics Corporation stock performance2025 Performance Recap & Community Trade Idea Sharing - newser.com
Dynamic Technology Lab Private Ltd Makes New Investment in Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation $HAE Shares Purchased by AQR Capital Management LLC - MarketBeat
Custom watchlist performance reports with Haemonetics Corporation2025 Technical Overview & Daily Stock Trend Watchlist - newser.com
Applying sector rotation models to Haemonetics CorporationShort Setup & AI Powered Market Trend Analysis - newser.com
Order flow analysis tools used on Haemonetics CorporationJuly 2025 Action & High Accuracy Swing Entry Alerts - newser.com
Haemonetics stock hits 52-week low at 50.62 USD By Investing.com - Investing.com Australia
Haemonetics stock hits 52-week low at 50.62 USD - Investing.com India
Visual analytics tools that track Haemonetics Corporation performanceWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
Zacks Research Forecasts Increased Earnings for Haemonetics - MarketBeat
Visual trend scoring systems applied to Haemonetics CorporationJuly 2025 Highlights & Risk Managed Investment Strategies - newser.com
13 Most Oversold Healthcare Stocks So Far in 2025 - Insider Monkey
Intech Investment Management LLC Sells 461 Shares of Haemonetics Corporation $HAE - Defense World
Aug Reactions: Is Haemonetics Corporation a top pick in the sector2025 Trading Recap & Verified Entry Point Signals - khodrobank.com
Is Haemonetics Corporation (NYSE:HAE) Trading At A 48% Discount? - simplywall.st
US Stocks Recap: What is the target price for URGN stock2025 Momentum Check & Real-Time Buy Signal Alerts - خودرو بانک
Published on: 2025-09-14 09:01:16 - newser.com
Zacks Research Has Negative View of Haemonetics Q1 Earnings - MarketBeat
Haemonetics Corporation (NYSE:HAE) Sees Large Increase in Short Interest - MarketBeat
Autotransfusion Systems Market Set for Rising Demand and Strong - openPR.com
Q1 EPS Estimates for Haemonetics Increased by Zacks Research - Defense World
Invenomic Capital Management LP Buys New Shares in Haemonetics Corporation $HAE - MarketBeat
RSI Alert: Haemonetics (HAE) Now Oversold - Nasdaq
Royal Bank of Canada Purchases 24,650 Shares of Haemonetics Corporation $HAE - MarketBeat
How sensitive is Haemonetics Corporation to inflation2025 Trading Recap & Free Low Drawdown Momentum Trade Ideas - Lancaster City Council
How moving averages guide Haemonetics Corporation tradingEarnings Risk Report & Long-Term Investment Growth Plans - Newser
What technical models suggest about Haemonetics Corporation’s comeback2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
Ranking Haemonetics Corporation among high performing stocks via toolsGlobal Markets & Smart Money Movement Tracker - Newser
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):